Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks rise as ECB pledges to speed up stimulus

Thu, 11th Mar 2021 17:00

(Alliance News) - Stocks in London ended higher on Thursday, amid a broad-based rally in European equities, as the European Central Bank committed to accelerating asset purchases.

The FTSE 100 index closed up 11.36 points, or 0.2%, at 6,736.96. The FTSE 250 ended up 126.43 points, or 0.6%, at 21,533.10. The AIM All-Share ended up 14.82 points, or 1.3%, at 1,197.52.

The Cboe UK 100 ended flat at 670.60, the Cboe UK 250 closed up 0.6%, at 19,142.33, the Cboe Small Companies ended 0.6% higher at 13,799.92.

In Paris the CAC 40 ended up 0.7%, while the DAX 30 in Frankfurt ended up 0.3%.

Spreadex analyst Connor Campbell said: "The ECB's promise to ramp up its bond buying program allowed the markets to maintain the week's positive glow on Thursday.

"It really has been a sharp turnaround from the bond yield-fearing, inflationary pressures-panicking losses that opened the month."

The euro stood at USD1.1960 at the European equities close, up from USD1.1900 late Wednesday in the wake of the European Central Bank's interest rate decision.

The Frankfurt-based central bank kept its interest rates on main refinancing operations, the marginal lending facility, and the deposit facility all unchanged at 0.00%, 0.25% and negative 0.50%, respectively. The ECB also left the size of its pandemic emergency purchase programme, or PEPP, unchanged at EUR1.85 trillion.

The ECB said after its latest monetary policy meeting that it will ramp up the pace of its pandemic emergency bond buys, in a bid to soothe market jitters about a rise in government borrowing costs and inflation.

While the ECB did not increase the overall amount of bond purchases planned, the announcement came as investor nervousness has already pushed up yields and despite the central bank acknowledging that inflation will likely run higher than expected in the short term.

"Rising yields are clearly a central issue given recent concerns, with the ECB taking action to drive down yields across the region. However, while the decision to front-load asset purchases under the PEPP scheme may have been designed to bring down yields, traders have seen right through it after initial declines were erased," said IG Group's Josh Mahony.

"Until the ECB decides to increase the overall size of the programme, today's decision to front-load PEPP purchases simply raises the chance of the scheme running its course earlier than expected. The clear correlation between yields and EURUSD meant we did see some initial weakness come into play after the announcement. However, just like the subsequent rise in yields, we are seeing EURUSD continue its recent rise later in the day," Mahony added.

On the London Stock Exchange, gambling firm Flutter Entertainment ended the best blue-chip performer, up 5.5% as it tracked shares in US peer DraftKings higher. Shares in Boston, Massachusetts-based DraftKings were up 3.3% in New York, having surged 9% on Wednesday following its investor day.

DraftKings said at its presentation to investors and analysts that it forecasts the total US online sports betting market represents a USD22 billion opportunity at 100% legalisation, which bodes well for the firm and main rival FanDuel - which is owned by Flutter.

Broker Davy, which reiterated its Outperform rating on Flutter, said: "Flutter Entertainment's current momentum confirms it is best positioned to capitalise on a wide-ranging set of global gaming opportunities. A clear leadership position in the US and fast-growing businesses in other key geographies are delivering strong top line progress."

At the other end of the large-caps HSBC ended the worst performer, down 4.7%, after the stock went ex-dividend, meaning new buyers no longer qualify for the latest payout. The Asia-focused bank also proposed to phase out all coal power financing by 2040 and affirmed its aim of committing up to USD1 trillion in green financing and investments.

Wm Morrison Supermarkets closed 1.8% lower after the grocer posted consensus-topping sales growth and profit, but noted it incurred GBP290 million in Covid-19-related costs.

In the financial year ended January 31, like-for-like sales growth, excluding both VAT and fuel, was up 8.6% annually. According to consensus compiled by Vuma, Morrisons was tipped to notch smaller like-for-like growth of 7.9%. In financial 2020, it posted a like-for-like sales fall of 0.8%, highlighting just how much the grocer's sales benefited from boosted demand amid Covid-19.

Annual revenue rose 0.4% to GBP17.60 billion from GBP17.54 billion. Pretax profit dropped 62% to GBP165 million from GBP435 million.

However, stripping out exceptional items, pretax profit beat forecasts. It came in at GBP201 million, down 51%, but marginally higher than the GBP200 million it was tipped to post, according to consensus.

Morrisons noted pretax profit before exceptional items would have been 5.6% higher year-on-year at GBP431 million, were it not for the GBP230 million of waived business relief rates it returned.

AstraZeneca closed down 2.5% after Danish health authorities suspended the use of the pharmaceutical group's Covid-19 vaccine as a precaution after some patients developed blood clots since receiving the jab. Norway later joined Denmark on putting the vaccine on hold.

Hikma Pharmaceuticals ended 1.9% lower after the generic drugmaker ended talks regarding the potential acquisition of GlaxoSmithKline's businesses in Egypt and Tunisia. GlaxoSmithKline closed down 0.6%.

In the FTSE 250, Marshalls closed up 8.2% after the concrete hard landscaping products maker said it made a strong start to 2021.

Marshalls reported a decline in 2020 revenue to GBP469.5 million from GBP541.8 million a year earlier, with pretax profit plummeting to GBP4.7 million from GBP69.9 million in 2019.

However, Marshalls said trading has started strongly in 2021, with sales at the end of February up 7% and orders up 12% compared to the same period in 2020.

At the other end of the midcaps, Helios Towers ended the worst performer, 6.0% lower. The telecom tower infrastructure company late Wednesday posted a rise in annual revenue against the backdrop of the global Covid-19 pandemic, but refrained from declaring a dividend.

The pound was quoted at USD1.3970 at the London equities close, up from USD1.3902 at the close Wednesday.

Against the yen, the dollar was trading at JPY108.51, down from JPY108.65 late Wednesday.

Stocks in New York were sharply higher at the London equities close as Congress passed US President Joe Biden's massive financial aid package and as jobs market improved.

The DJIA was up 0.9%, the S&P 500 index up 1.2% and the Nasdaq Composite up 2.1%.

US initial jobless claims decreased by 42,000 last week to 712,000 claims on the prior week's 754,000, both beating expectations and coming in at the lowest since November.

"The key takeaway from the initial jobless claims data is that initial claims are still high, but at least they are moving in a direction that suggests the economy is finding its growth stride again," said market analyst Patrick O'Hare at Briefing.com.

Brent oil quoted at USD69.32 a barrel at the equities close, up sharply from USD67.85 at the close Wednesday.

"Crude prices benefited from the broader risk-on rally and held onto gains after the monthly OPEC report showed a weaker demand outlook in the first half of the year due to Europe's restrictive measures to control COVID-19. Energy market traders are still expecting a tight oil market as OPEC+ will only raise output once the recovery in oil demand is clear," Oanda Markets analyst Edward Moya explained.

Gold was quoted at USD1,722.35 an ounce at the London equities close, slightly higher against USD1,719.15 late Wednesday.

The economic events calendar on Friday has the monthly UK GDP reading and industrial production data at 0700 GMT and US producer prices at 1330 GMT.

The UK corporate calendar on Friday has annual results from shopping centre operator Hammerson and a trading statement from housebuilder Berkeley Group.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.